TOP GUIDELINES OF ELIMUSERTIB

Pharmacological inhibition in the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; generally known as FRAP-related protein (FRP1)) has emerged to be a promising method for cancer procedure that exploits synthetic lethal interactions with proteins involved with DNA problems restore, overcomes resistance to other therap